Activated protein C ameliorates impaired renal microvascular oxygenation and sodium reabsorption in endotoxemic rats

Intensive Care Medicine Experimental

Volumn 1, Issue 1, 2013, Pages

  Almac, Emre ^a,b   Johannes, Tanja ^a,c   Bezemer, Rick ^a   Mik, Egbert G ^c   Unertl, Klaus E ^d   Groeneveld, Ab Johan ^c   Ince, Can ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Activated protein C; AKI; APC; Endotoxemia; Microcirculation

Indexed keywords

EID: 84922586751     PISSN: None     EISSN: 2197425X     Source Type: Journal    
DOI: 10.1186/2197-425X-1-5     Document Type: Article

References (47)

1. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P: Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 1996, 11: 293–299. 10.1093/oxfordjournals.ndt.a027256 DOI: 10.1093/oxfordjournals.ndt.a027256
2. Oppert M, Engel C, Brunkhorst FM, Bogatsch H, Reinhart K, Frei U, Eckardt KU, Loeffler M, John S, German Competence Network Sepsis (Sepnet): Acute renal failure in patients with severe sepsis and septic shock—a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol Dial Transplant 2008, 23: 904–909. DOI: 10.1093/ndt/gfm610
3. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P, VA/NIH Acute Renal Failure Trial Network: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008, 359: 7–20. DOI: 10.1056/NEJMoa0802639
4. Molitoris BA, Sutton TA: Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int 2004, 66: 496–499. 10.1111/j.1523-1755.2004.761_5.x DOI: 10.1111/j.1523-1755.2004.761_5.x
5. Johannes T, Mik EG, Ince C: Non-resuscitated endotoxemia induces microcirculatory hypoxic areas in the renal cortex in the rat. Shock 2009, 31: 97–103. 10.1097/SHK.0b013e31817c02a5 DOI: 10.1097/SHK.0b013e31817c02a5
6. Linas SL, Whittenburg D, Repine JE: Role of neutrophil derived oxidants and elastase in lipopolysaccharide-mediated renal injury. Kidney Int 1991, 39: 618–623. 10.1038/ki.1991.73 DOI: 10.1038/ki.1991.73
7. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004, 351: 159–169. 10.1056/NEJMra032401 DOI: 10.1056/NEJMra032401
8. Fourrier F: Recombinant human activated protein C in the treatment of severe sepsis: an evidence-based review. Crit Care Med 2004, 32: S534-S541. 10.1097/01.CCM.0000145944.64532.53 DOI: 10.1097/01.CCM.0000145944.64532.53
9. Bernard GR: Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Crit Care Med 2003, 31: S85-S93. 10.1097/00003246-200301001-00012 DOI: 10.1097/00003246-200301001-00012
10. Esmon CT: Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001, 29: S48-S51. DOI: 10.1097/00003246-200107001-00018
11. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699–709. 10.1056/NEJM200103083441001 DOI: 10.1056/NEJM200103083441001
12. Favory R, Lancel S, Marechal X, Tissier S, Neviere R: Cardiovascular protective role for activated protein C during endotoxemia in rats. Int Care Med 2006, 32: 899–905. 10.1007/s00134-006-0166-x DOI: 10.1007/s00134-006-0166-x
13. Grinnell BW, Joyce D: Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis. Crit Care Med 2001, 29: S53-S60. DOI: 10.1097/00003246-200107001-00020
14. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Fertmann J, Schildberg FW, Menger MD: Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med 2004, 32: 1011–1017. 10.1097/01.CCM.0000120058.88975.42 DOI: 10.1097/01.CCM.0000120058.88975.42
15. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE: Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987, 79: 918–925. 10.1172/JCI112902 DOI: 10.1172/JCI112902
16. Gupta A, Rhodes GJ, Berg DT, Gerlitz B, Molitoris BA, Grinnell BW: Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am J Physiol Renal Physiol 2007, 293: F245-F254. 10.1152/ajprenal.00477.2006 DOI: 10.1152/ajprenal.00477.2006
17. Gupta A, Berg DT, Gerlitz B, Sharma GR, Syed S, Richardson MA, Sandusky G, Heuer JG, Galbreath EJ, Grinnell BW: Role of protein C in renal dysfunction after polymicrobial sepsis. J Am Soc Nephrol 2007, 18: 860–867. 10.1681/ASN.2006101167 DOI: 10.1681/ASN.2006101167
18. Gupta A, Gerlitz B, Richardson MA, Bull C, Berg DT, Syed S, Galbreath EJ, Swanson BA, Jones BE, Grinnell BW: Distinct functions of activated protein C differentially attenuate acute kidney injury. J Am Soc Nephrol 2009, 20: 267–277. 10.1681/ASN.2008030294 DOI: 10.1681/ASN.2008030294
19. Gupta A, Williams MD, Macias WL, Molitoris BA, Grinnell BW: Activated protein C and acute kidney injury: selective targeting of PAR-1. Curr Drug Targets 2009, 10: 1212–1226. 10.2174/138945009789753291 DOI: 10.2174/138945009789753291
20. Mizutani A, Okajima K, Uchiba M, Noguchi T: Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000, 95: 3781–3787.
21. Martí-Carvajal AJ, Solà I, Gluud C, Lathyris D, Cardona AF: Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients. Cochrane Database Syst Rev 2012, 12: 12.
22. Johannes T, Mik EG, Ince C: Dual-wavelength phosphorimetry for determination of cortical and subcortical microvascular oxygenation in rat kidney. J Appl Physiol 2006, 100: 1301–1310. DOI: 10.1152/japplphysiol.01315.2005
23. 2 and kidney oxygen consumption in rats by a near-infrared phosphorescence lifetime technique. Am J Physiol Renal Physiol 2008, 294: F676-F681. 10.1152/ajprenal.00569.2007 DOI: 10.1152/ajprenal.00569.2007
24. Dunphy I, Vinogradov SA, Wilson DF: Oxyphor R2 and G2: phosphors for measuring oxygen by oxygen-dependent quenching of phosphorescence. Anal Biochem 2002, 310: 191–198. 10.1016/S0003-2697(02)00384-6 DOI: 10.1016/S0003-2697(02)00384-6
25. Klenzak J, Himmelfarb J: Sepsis and the kidney. Crit Care Clin 2005, 21: 211–222. 10.1016/j.ccc.2005.01.002 DOI: 10.1016/j.ccc.2005.01.002
26. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW: Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001, 276: 11199–11203. 10.1074/jbc.C100017200 DOI: 10.1074/jbc.C100017200
27. Bezemer R, Faber DJ, Almac E, Kalkman J, Legrand M, Heger M, Ince C: Evaluation of multi-exponential curve fitting analysis of oxygen-quenched phosphorescence decay traces for recovering microvascular oxygen tension histograms. Med Biol Eng Comput 2010, 48: 1233–1242. 10.1007/s11517-010-0698-7 DOI: 10.1007/s11517-010-0698-7
28. Weinberg JR, Boyle P, Thomas K, Murphy K, Tooke JE, Guz A: Capillary blood cell velocity is reduced in fever without hypotension. Int J Microcirc Clin Exp 1991, 10: 13–19.
29. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166: 98–104. 10.1164/rccm.200109-016OC DOI: 10.1164/rccm.200109-016OC
30. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004, 32: 1825–1831. 10.1097/01.CCM.0000138558.16257.3F DOI: 10.1097/01.CCM.0000138558.16257.3F
31. Ince C, Sinaasappel M: Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999, 27: 1369–1377. 10.1097/00003246-199907000-00031 DOI: 10.1097/00003246-199907000-00031
32. Ince C: The microcirculation is the motor of sepsis. Crit Care 2005, 9: S13-S19. 10.1186/cc3753 DOI: 10.1186/cc3753
33. Fisher CJ Jr, Yan SB: Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 2000, 28: S49-S56. 10.1097/00003246-200009001-00011 DOI: 10.1097/00003246-200009001-00011
34. Legrand M, Mik EG, Johannes T, Payen D, Ince C: Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 2008, 14: 502–516. DOI: 10.2119/2008-00006.Legrand
35. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Molitoris BA: Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 2003, 285: F191-F198. DOI: 10.1152/ajprenal.00042.2003
36. Yamamoto T, Tada T, Brodsky SV, Tanaka H, Noiri E, Kajiya F, Goligorsky MS: Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol 2002, 282: F1150-F1155. DOI: 10.1152/ajprenal.00310.2001
37. Hörbelt M, Lee SY, Mang HE, Knipe NL, Sado Y, Kribben A, Sutton TA: Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiol Renal Physiol 2007, 293: F688-F695. 10.1152/ajprenal.00452.2006 DOI: 10.1152/ajprenal.00452.2006
38. Schnackenberg CG: Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 2002, 282: R335-R342. DOI: 10.1152/ajpregu.00605.2001
39. Li C, Jackson RM: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002, 282: C227-C241. 10.1152/ajpcell.00112.2001 DOI: 10.1152/ajpcell.00112.2001
40. Jassem W, Fuggle SV, Rela M, Koo DD, Heaton ND: The role of mitochondria in ischemia/reperfusion injury. Transplantation 2002, 73: 493–499. 10.1097/00007890-200202270-00001 DOI: 10.1097/00007890-200202270-00001
41. Pan Y, Mansfield KD, Bertozzi CC, Rudenko V, Chan DA, Giaccia AJ, Simon MC: Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol 2007, 27: 912–925. 10.1128/MCB.01223-06 DOI: 10.1128/MCB.01223-06
42. Coremans JM, Van Aken M, Naus DC, Van Velthuysen ML, Bruining HA, Puppels GJ: Pretransplantation assessment of renal viability with NADH fluorimetry. Kidney Int 2000, 57: 671–683. 10.1046/j.1523-1755.2000.00889.x DOI: 10.1046/j.1523-1755.2000.00889.x
43. 2. J Appl Physiol 1990, 68: 833–842.
44. Kwon O, Nelson WJ, Sibley R, Huie P, Scandling JD, Dafoe D, Alfrey E, Myers BD: Backleak, tight junctions, and cell-cell adhesion in postischemic injury to the renal allograft. J Clin Invest 1998,101(10):2054–2064. 10.1172/JCI772 DOI: 10.1172/JCI772
45. Lewy JE, Windhager EE: Peritubular control of proximal tubular fluid reabsorption in the rat kidney. Am J Physiol 1968,214(5):943–954.
46. Wargenau M, Bepperling F, Baron JF: The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg 2002,95(3):544–551.
47. 2 in a normotensive rat model of endotoxemia. Crit Care 2006,10(3):R88. 10.1186/cc4948 DOI: 10.1186/cc4948